Eagle Pharmaceuticals Alpha and Beta Analysis
| EGRXDelisted Stock | USD 1.99 0.02 1.02% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eagle Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eagle Pharmaceuticals over a specified time horizon. Remember, high Eagle Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eagle Pharmaceuticals' market risk premium analysis include:
Beta (0.32) | Alpha (1.17) | Risk 8.64 | Sharpe Ratio (0.29) | Expected Return (2.47) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Eagle |
Eagle Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eagle Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eagle Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eagle Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eagle Pharmaceuticals' performance over market.| α | -1.17 | β | -0.32 |
Eagle Pharmaceuticals Fundamentals Vs Peers
Comparing Eagle Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eagle Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Eagle Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eagle Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Eagle Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Eagle Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Eagle Pharmaceuticals to competition |
| Fundamentals | Eagle Pharmaceuticals | Peer Average |
| Return On Equity | 0.0488 | -0.31 |
| Return On Asset | 0.0663 | -0.14 |
| Profit Margin | 0.05 % | (1.27) % |
| Operating Margin | 0.16 % | (5.51) % |
| Current Valuation | 82.05 M | 16.62 B |
| Shares Outstanding | 12.96 M | 571.82 M |
| Shares Owned By Insiders | 12.02 % | 10.09 % |
Eagle Pharmaceuticals Opportunities
Eagle Pharmaceuticals Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Eagle Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eagle or other pink sheets. Alpha measures the amount that position in Eagle Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Eagle Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Eagle Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eagle Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Eagle Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Eagle Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Eagle Pharmaceuticals' management manipulating its earnings.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of September 2023 Last Quarter Report | View |
Build Portfolio with Eagle Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Eagle Pink Sheet
If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |